W H Burgess
Overview
Explore the profile of W H Burgess including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
3227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drohan W, Miekka S, Griko Y, Forng R, Stafford R, Hill C, et al.
Dev Biol (Basel)
. 2005 Jan;
118:133-8.
PMID: 15645683
This paper describes gamma irradiation of a biotherapeutic product under conditions (the Clearant Process") that protect proteins and foster inactivation of viruses and other pathogens. The treated product was immunoglobulin...
2.
Xue L, Tassiopoulos A, Woloson S, Stanton Jr D, Ms C, Hampton B, et al.
J Vasc Surg
. 2001 Mar;
33(3):554-60.
PMID: 11241127
Objective: Cardiovascular tissue engineering approaches to vessel wall restoration have focused on the potent but relatively nonspecific and heparin-dependent mesenchymal cell mitogen fibroblast growth factor 1 (FGF-1). We hypothesized that...
3.
Maddox E, Zhan M, Mundy G, Drohan W, Burgess W
Tissue Eng
. 2000 Sep;
6(4):441-8.
PMID: 10992439
The use of human demineralized bone matrix (DBM) powder in periodontal and orthopedic applications is limited by the variability in the osteoinductive or osteoconductive properties of the material. The goal...
4.
Xue L, Shireman P, Hampton B, Burgess W, Greisler H
J Surg Res
. 2000 Jul;
92(2):255-60.
PMID: 10896831
Background: The structure/function relationships of fibroblast growth factor 1 (FGF-1) are being investigated using site mutation, yielding novel structures with potential clinical applicability for modulating tissue responses to vascular interventions....
5.
Grieb T, Burgess W
J Cell Physiol
. 2000 Jun;
184(2):171-82.
PMID: 10867641
The fibroblast growth factor-1 (FGF-1) mitogenic signal transduction pathway is not well characterized, and evidence indicates that FGF-1 binding to and activation of cell-surface receptors is not solely sufficient for...
6.
Shireman P, Xue L, Maddox E, Burgess W, Greisler H
J Vasc Surg
. 2000 Feb;
31(2):382-90.
PMID: 10664506
Objective: Site-directed mutagenesis is an important technique that can alter cytokine function, thereby eliciting desired responses. S130K is a mutation of fibroblast growth factor-1 (FGF-1), with lysine replacing serine in...
7.
Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2
Klein S, Carroll J, Chen Y, Henry M, HENRY P, Ortonowski I, et al.
J Biol Chem
. 2000 Feb;
275(5):3150-7.
PMID: 10652299
The post-translational methylation of the N-terminally extended or high molecular weight (HMW) forms of fibroblast growth factor-2 (FGF-2) has been shown to affect the nuclear accumulation of the growth factor....
8.
Fedi P, Bafico A, Nieto Soria A, Burgess W, Miki T, Bottaro D, et al.
J Biol Chem
. 1999 Jun;
274(27):19465-72.
PMID: 10383463
In an effort to isolate novel growth factors, we identified a human protein, designated Sk, that co-eluted with Neuregulin during chromatographic separation of conditioned medium from the SK-LMS-1 human leiomyosarcoma...
9.
Dunstan C, Boyce R, Boyce B, Garrett I, Izbicka E, Burgess W, et al.
J Bone Miner Res
. 1999 Jun;
14(6):953-9.
PMID: 10352104
There are no universally accepted agents that will substantially increase bone mass in osteoporotic patients. A number of peptides important in normal bone formation, such as members of the transforming...
10.
Shireman P, Hampton B, Burgess W, Greisler H
J Vasc Surg
. 1999 May;
29(5):852-61; discussion 862.
PMID: 10231637
Purpose: Fibrin glue (FG) has been used as a delivery system for bioactive agents on grafts and angioplasty sites. Reports from two different institutions suggest that heparin concentrations of 500...